Viewing Study NCT04468685



Ignite Creation Date: 2024-05-06 @ 2:54 PM
Last Modification Date: 2024-10-26 @ 1:40 PM
Study NCT ID: NCT04468685
Status: COMPLETED
Last Update Posted: 2021-01-12
First Post: 2020-07-08

Brief Title: Ondansetron Effect on Pain Relief After Laparoscopic Cholecystectomy
Sponsor: National Hepatology Tropical Medicine Research Institute
Organization: National Hepatology Tropical Medicine Research Institute

Study Overview

Official Title: Efficacy of Intraperitoneal Ondansetron Administration on Pain Relief After Laparoscopic Cholecystectomy
Status: COMPLETED
Status Verified Date: 2021-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Laparoscopic cholecystectomy LC is an easy procedure characterized by its minimal invasiveness less post-operative pain and early recovery when compared to the open conventional cholecystectomy However patients who have undergone LC still complain of postoperative pain It has been reported that ondansetron produces numbness when injected under the skin and has local anesthetic effect that is 15 times more potent than lidocaine the most widely used local anesthetic and probably explains its antiemetic action It possesses anti-inflammatory anesthetic and analgesic properties by its multifaceted actions as a 5-HT3 receptor antagonist a Na channel blocker and a mu-opioid agonist which may have a potential role in decreasing pain The study aimed to demonstrate the effectiveness of IP administration of ondansetron on pain management post LC
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None